Cite

HARVARD Citation

    Feldman, S. et al. (2019). Evaluating Costs of Biologic Drugs for the Treatment of Moderate-to-Severe Psoriasis in the United States. Journal of psoriasis and psoriatic arthritis. 4 (3), pp. 133-142. [Online]. 
  
Back to record